Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HX-461

K-Number: K120545 · 2012-10-23

Decision Date2012-10-23
Product CodeDXN
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

HX-461 is the device name listed in this FDA 510(k) record. The listed applicant is Seers Technology Co., Ltd.. It received FDA 510(k) clearance on 2012-10-23 under 510(k) number K120545. The device is classified under product code DXN. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HX-461?

HX-461 is a medical device that received FDA 510(k) clearance on 2012-10-23. The listed applicant is Seers Technology Co., Ltd.. The 510(k) number is K120545.

When did HX-461 receive FDA 510(k) clearance?

HX-461 received FDA 510(k) clearance on 2012-10-23, under 510(k) number K120545.

Who is the listed applicant for HX-461?

The FDA 510(k) record lists Seers Technology Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for HX-461?

The FDA product code for HX-461 is DXN.

Other records listing Seers Technology Co., Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: DXN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑